Parami Partners is a healthcare-focused private equity platform investing in injectables, formulations, vaccines and medical devices through control-oriented strategies, combining deep operating expertise with the capital and conviction of seasoned healthcare entrepreneurs.
Who we are
A Healthcare-Focused Private Equity Firm
Parami Partners invests in and builds regulated healthcare businesses. We combine disciplined investing, clear strategic direction, patient capital and embedded operating leadership to create sustainable long-term value.
$XYZ
AUM
What we do
Building and Transforming Regulated Healthcare Businesses
Parami acquires controlling stakes in businesses across vaccines, biologics, sterile injectables and medical devices. Our team becomes embedded in executive leadership and day-to-day operations, taking direct responsibility for strategy and execution.
From stabilizing operations and strengthening governance to building capabilities, developing portfolios, forming partnerships and expanding markets, we transform complex businesses and position them for sustainable growth.
Proven Operational Value Creation
Our investments in Sagent Pharmaceuticals (2023), Shantha Biologics (April 2024) and TransCath Medical Devices demonstrate our ability to execute control transactions, build greenfield platforms, and lead transformation across manufacturing, portfolio strategy, and commercial operations.